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Abstract
Background: The aim of the study was to examine the
practicability and implementation efficacy of an alco-
hol outpatient detoxification model and the concomi-
tant ‘motivational’ psychotherapeutic approach. Meth-
od: This was an open prospective study to examine the
implementation efficacy, practicability and medical safe-
ty of a novel psychotherapy-based, integrated outpatient
detoxification model in alcohol-dependent patients. Pa-
tients were carefully screened for relevant neuropsy-
chiatric disorders and other exclusion criteria and then
seen on a daily outpatient basis for 5–7 days. Patients
received psychotropic or other medication, if necessary
(CIWA-A score 116). Beside management of withdrawal
symptoms, psychotherapeutic interventions were con-
ducted to motivate the patient for further alcohol thera-
py. Results: Of 557 patients screened 331 entered the
program. For medical reasons 226 patients had to be
admitted for inpatient detoxification, 122 patients in a
special alcohol unit, 101 patients in a general hospital.
198 (60%) of the outpatients received psychotropic medi-
cation during treatment. 312 (94%) of these patients suc-
cessfully completed treatment. 301 (91% of the initial
sample) patients entered a consecutive 3-month motiva-
tional phase of a two-phase alcohol treatment program.
139 (46%) patients successfully completed the 1-year
consecutive outpatient treatment. Conclusions: Outpa-
tient detoxification, at least in a highly structured frame,
can be considered as a safe and efficient therapeutic
approach. The data of this study also indicate that psy-
chotherapeutic interventions and motivation for further
abstinence and treatment may work in alcohol-depen-
dent patients on an outpatient basis. Further controlled
trials are necessary to compare the effects of outpatient
versus inpatient withdrawal.
Copyright © 2004 S. Karger AG, Basel
Introduction
Alcoholism is one of the most widespread psychiatric
disorders in Western countries. Current treatment ser-
vices only partially meet patients needs. In a comprehen-
sive review of alcohol treatment, McCrady and Langen-
bucher [1996] concluded that a reformed health care sys-
tem should include full benefits for outpatient care which
can be considered as an important task of community
medicine. But the issue of outpatient detoxification is still
controversial with most patients being treated in hospi-
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tals, at least in Germany and most other European coun-
tries. While favorable results of outpatient or day-hospital
rehabilitation programs for substance use have been re-
ported by Cornwall and Blood [1998], McKay et al. [1995,
1998], Ehrenreich et al. [2000] and Willenbring et al.
[1995], among others, outpatient detoxification is still a
widely neglected issue in alcohol therapy [Fiellin et al.,
2000; Prater et al., 1999]. Wiseman et al. [1998] reported
that 85% of 108 patients enrolled in an outpatient detoxi-
fication program successfully completed detoxification
without medical complications. Using a symptom-trig-
gered pharmacological treatment approach, only 38% of
patients received medication (chlordiazepoxide). In
another sample of 577 patients consecutively referred to
an ambulatory detoxification program, 453 completed
outpatient detoxification [Wiseman et al., 1997]. Similar-
ly Collins et al. [1990] reported a 79% completion rate in a
sample of 76 patients using a fixed-dose regime. Patients
had initially received 30–40 mg diazepam with gradual
withdrawal over a 5- to 7-day period. Little is known
about the mid- to long-term effects of outpatient alcohol
detoxification. Collins et al. [1990] speculated that there
were no particular reasons why outpatient detoxification
should have any greater or lesser effect on long-term out-
come than inpatient treatment, but currently there are few
studies to support that notion.
Psychotherapeutic interventions are of great relevance
for further treatment outcome. Current therapy recom-
mendations suggest integrating psychotherapeutic ‘moti-
vational’ elements into the detoxification period to moti-
vate the patient for further therapy and abstinence
[Feuerlein et al., 1998; John, 1991; John et al., 2000].
Based on the concepts of Miller and Rollnick [1991,
1999], motivational techniques today are integrated into
the detoxification phase [Feuerlein et al., 1998]. In Ger-
many the integration of motivational aspects into detoxi-
fication is named ‘qualified detoxification’ (qualifizierte
Entgiftung) [Mann, 2002]. A number of different motiva-
tional approaches varying in their intensity have been
integrated into the early intervention or detoxification of
alcoholics [John, 1991; John et al., 2000]. A major aim of
motivational therapy during detoxification is to increase
the patients own activity towards further therapy and into
the ‘action phase’ according to the concept of Miller and
Rollnick [1991, 1999]. In Germany the efficacy of 1- to
3-week motivational therapy during inpatient detoxifica-
tion has been studied [John, 1991; Schwoon, 1990] but
similar interventions during outpatient detoxification
have not been the subject of research.
We report data of a psychotherapy-oriented alcohol
outpatient program which was supported as a model pro-
ject by major health insurances. This article describes the
methods of the program and offers results on feasibility
and outcome. Following the implementation of a struc-
tured outpatient detoxification program in an outpatient
clinic, a prospective 1-year evaluation study on the appli-
cability of this program and clinical outcome of the
patients was performed.
Subjects and Methods
This was an open, prospective study to examine the implementa-
tion efficacy, medical safety and practicability of outpatient detoxifi-
cation of alcohol-dependent patients.
The major aims of the study were to evaluate: (1) the acceptance
and efficacy of outpatient alcohol detoxification; (2) the number of
patients screened and included; (3) the number of patients success-
fully detoxified, and (4) the medical complications.
The efficacy of the concomitant psychotherapeutic approach was
also evaluated. Patients were examined 12 months after detoxi-
fication to assess whether (1) they had completed the consecutive
1-year outpatient rehabilitation program for alcohol dependence,
and (2) were abstinent or had relapsed at follow-up.
Inclusion Criteria
Patients had to meet ICD-10 [Dilling et al., 1994] and DSM-IV
[American Psychiatric Association, 1994] criteria for alcohol depen-
dence. Patients were requested to be willing to participate in an out-
patient treatment and detoxification for alcohol dependence. Also
one close relative (spouse, etc.) or friend was required as support for
the patient at home (not mandatory).
Exclusion Criteria
Polysubstance use, history of severe alcohol-related disorders (sei-
zures, alcohol psychosis), major psychiatric disorders (e.g. schizophre-
nia, suicidality), severe cognitive deficits, severe medical disorders
(pneumonia, tuberculosis or other infectious diseases), head injury,
severe liver cirrhosis, erosive gastritis, pancreatitis, reduced physical
state and cardiovascular disorders were reasons for exclusion.
Treatment Facility
The treatment facility is an outpatient clinic (Klientenzentrierte
Problemberatung Dachau, KPB, Fachambulanz für Suchterkran-
kungen) specialized in the treatment of substance use disorders
which offers a comprehensive two-step rehabilitation model for alco-
hol dependence: A 3-month motivational treatment phase was fol-
lowed by a 6- to 9- (mean 8)-month rehabilitation program (80–120
group and individual therapy sessions). The motivational phase is
usually paid for by the health insurers, the rehabilitation phase by
pension funds.
Details of the program have been described elsewhere [Soyka et
al., 1997, 2002].
Motivational Phase
The motivational phase starts immediately after outpatient de-
toxification. During the motivational phase patients are seen several
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Fig. 1. Overview: Clinical concept
outpatient treatment facility.
times a week. An extensive internal/neurological examination and a
detailed psychodiagnostic examination are performed. The weekly
setting during the motivational phase consists of a ‘motivational-
enhancement group’ (cognitive-oriented therapy, including Jacobson
progressive muscular relaxation) and a so-called ‘support group’
(body and emotional-oriented therapy, autogenic training) and four
individual psychotherapy/medical sessions.
Rehabilitation Phase
The therapeutic concept is integrative and eclectic, and includes
different psychotherapeutic methods and approaches.
The therapy program comprises 80 to maximum 120 therapy ses-
sions, mostly group therapy but also individual therapy, including
behavioral/cognitive, psychodynamic and systemic oriented therapy
sessions. Optional elements are self-help groups, but also other ele-
ments such as psychodrama or muscular relaxation, among others,
are also used.
During the entire treatment abstinence is checked by repeated
breathalyzer tests as well as blood laboratory tests. The therapeutic
team comprise 2–3 psychiatrists (physicians), 2 full-time psychother-
apists, several part-time psychologists, and 1 social worker. As for
inpatient treatment clinical coworkers of the outpatient clinic must
fulfill qualifications to be acknowledged by pension funds as thera-
pists.
The outcome of the rehabilitation program has been the subject
of research before. An earlier retrospective follow-up study had
revealed a 46% abstinence rate 18 months after treatment [Soyka et
al., 1997]; a prospective 3-year follow-up study is currently being
conducted. The different treatment steps and options of the outpa-
tient clinic are given in figure 1.
Outpatient Detoxification Model
The outpatient detoxification program was developed by the
principal investigator (first author) and introduced into clinical prac-
tice in 1998 [for methods see, Soyka et al., 1999, 2001].
Patients are initially seen in the outpatient clinic. Patients are
referred for participation in the two-step rehabilitation program
described above. Before that detoxification must have been per-
formed either on an outpatient or inpatient basis. After detoxifica-
tion patients are supposed to enter the alcohol treatment program.
The time schedule of outpatient detoxification is given in figure 1.
A major tool is the assessment of possible risk factors before treat-
ment begin. Patients are carefully screened for major psychiatric (de-
pression, schizophrenia, polytoxicomania, etc.) and somatic/neuro-
logic disorders (seizures, history of alcohol psychoses) using a num-
ber of diagnostic instruments (ECG, drug screening, detailed labora-
tory examination).
For assessment of alcohol withdrawal the CIWA-A scale [Shaw et
al., 1981; Sullivan et al., 1989] is used. The validated German ver-
sion of the CIWA-A scale by Stuppaeck et al. [1994] is a 12-item scale
which comprises following items: blood pressure (RR), pulse rate,
respiratory rate, body temperature, seizures, nausea/vomiting, trem-
or, hyperhidrosis, tactile/auditory/visual disturbances, orientation,
concentration, nervousness/anxiety and headache. In contrast to the
original scale by Sullivan et al. [1989] with grades from 0 to 7 the
German CIWA-A-scale uses grades from 1 (non existent) to 6 (maxi-
mum), except for seizures. The total minimum score of the scale is 11
(no symptoms).
Additionally the Alcohol Withdrawal Scale (AWS) is used [Wet-
terling et al., 1995a, b]. This is an 11-item scale with grades from 0 =
none to 3 = severe.
Procedure
During detoxification, patients are seen on a daily basis for 5–7
(maximum 10) days. Beside somatic and psychiatric examinations,
group therapy and individual motivational-oriented psychotherapy
(minimum 3 h during detoxification) are offered during treatment
(fig. 2; see also below). Withdrawal symptoms were measured on a
daily basis (CIWA-A scale, AWS scale). Patients have to give written
consent before starting treatment.
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In case of severe medical complications patients will be trans-
ferred to hospital, preferably the Psychiatric Hospital of the Univer-
sity of Munich.
Medication
Patients received vitamins (especially B1) and minerals (Na, K,
Mg) if necessary. Although medication in general was given on an
individualized decision basis, the literature [Mayo-Smith, 1997] and
our own experience suggest that patients with a CIWA-A score of
116 or an AWS score of 16 require medication. If the patient experi-
enced withdrawal symptoms as measured by the AWS (16 mean val-
ue for withdrawal symptoms) and the CIWA-A scale (116) pharma-
cotherapy was initiated.
Initially to avoid tranquilizers/hypnotics with abuse potential
(benzodiazepines and chlormethiazole) a symptom-triggered phar-
macological treatment either with doxepine (25–50 mg, maximum
100 mg) or clonidine (systolic hypertension, RR 1180 mm Hg) was
initiated. In leading German textbooks of clinical psychopharma-
cology this antidepressant is recommended for treatment of alcohol
withdrawal [Benkert and Hippius, 1996]. Although no standard fixed
dose regime was used the usual medication scheme in case of hyper-
tension (1160/100 mm Hg) was 3 ! 2!75 Ìg clonidine on days 1
and 2 and 1–3 ! 75 Ìg on day 3. Clonidine is a first-line medication
for hypertension in alcohol withdrawal [for review see, Soyka et al.,
1999]. For sleep disorder 25 mg doxepine was given in the evening;
in case of severe agitation, restlessness or other vegetative symptom-
atology the dose was increased to 3 ! 25 mg doxepine. Later on dur-
ing the program a combination of carbamazepine and tiapride was
used for outpatient detoxification [Soyka et al., 2002].
Motivational Psychotherapy during Detoxification
Based on the concept of Miller and Rollnick [1991, 1999], the
3-hour motivational oriented psychotherapy during outpatient treat-
ment aimed to motivate patient for further therapy and abstinence.
In two individual sessions the patient’s alcohol history and its conse-
quences for work, health and family were addressed. The patient was
advised to remain abstinent in the future, and arguments for (or
against) further abstinence were balanced. In the next step the
patient’s personal situation and future perspectives were addressed.
Possible deficits in various areas were the subject of discussion. The
patient was supposed to learn that his psychosocial situation (work-
place, family, finance) will benefit from further abstinence. Finally
possible psychotherapeutic interventions in the post-detoxification
period were outlined and possibly organized. Based on the patient’s
own alcohol history further alcohol therapy was initiated focusing on
outpatient rehabilitation.
The motivational group therapy session had the main aim to
reduce the patient’s resistance to treatment and was also used as a
diagnostic instrument to explore the patient’s interaction with others
(feedback). In the group therapy the patient could also report his per-
sonal experience with alcohol.
Follow-Up Interview
Patients were personally interviewed and examined after 12
months. Breathalyzer tests and if possible collateral information
from the spouse or other family members or GPs were used to verify/
exclude abstinence. Biological parameters like Á-glutamyltransferase
and carbohydrate-deficient transferrin were measured if the patient’s
self-report seemed to be inconsistent with the clinical findings.
Fig. 2. Withdrawal symptoms over 6 days as measured by the
CIWA-A scale (mean values). S = Standard deviation.
Table 1. Baseline sociodemographic characteristics of patients
n %
Total 331 100
Male 222 67
Female 109 33
Working/housewife 247 75
Unemployed 84 25
Living in partnership 232 70
Divorced 95 28
Single at present 99 30
Children 158 48
No children 173 52
Previous alcohol treatment
(rehabilitation, psychotherapy) 106 32
Previous alcohol detoxification 149 45
Results
Of 557 patients screened between July 1998 and June
2003, 331 (59%) entered the program. For medical rea-
sons 223 patients had to be transferred to a hospital.
Three patients decided to be detoxified by their general
practitioner. Patient characteristics are given in table 1.
Of the 331 patients 222 (67%) were male and 109 (33%)
female. Mean age was 44.3 (24–72, SD 8.5) years, mean
duration of alcohol dependence 9.8 (SD 9.0) years. The
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Fig. 3. Withdrawal symptoms over 6 days as measured by the AWS
scale (mean values). S = Standard deviation.
mean Á-glutamyltransferase value was 99 (SD 11.0) U/l at
baseline. Mean alcohol consumption in the month prior
to baseline was reported to be 156 (SD 72) g/day.
106 of 331 patients (32%) had been previously treated
for alcohol dependence in a rehabilitation program. 149
of 331 (45%) had been treated as inpatients for alcohol
detoxification.
Although patients were asked to reduce alcohol con-
sumption before treatment, breathalyzer tests showed
that 99 of 331 (30%) patients were still intoxicated at the
begin of withdrawal (blood alcohol concentration 0.1 and
2.7).
195 (58.9%) patients received medication. Withdrawal
symptoms were measured on a daily basis (13-item
CIWA-A scale, AWS scale). There were no serious medi-
cal complications, especially no seizures, alcohol with-
drawal delirium or other neurological disorders.
58 of 195 (30%) patients received doxepine, 68 of 195
(35%) clonidine, 29 of 195 (15%) in combination, 39 of
195 (20%) patients other medications (ß-blocker, carba-
mazepine/tiapride, other antidepressants).
The mean CIWA-A score on day 1 was 18.1 (13–27)
which gradually declined over the treatment period
(fig. 2, 3). The same was true for the AWS score.
Outcome
An overview of treatment outcome in patients admit-
ted for alcohol detoxification is given in figures 4 and 5.
Of the 331 patients enrolled, 312 (94%) successfully
terminated treatment. 19 (6%) patients dropped out of
treatment. Reasons for dropping out were: alcohol relapse
(n = 10); lack of motivation; noncompliance, or problems
at work or with health insurance (n = 9).
Of the 312 patients who successfully ended outpatient
detoxification, 301 (96%) entered the first motivational-
oriented treatment phase at the outpatient clinic. 11 (4%)
opted for psychotherapy in another facility.
12-Month Outcome
Patients were examined 12 months after outpatient
detoxification by personal interview. Data of the 12-
month follow-up evaluation indicate the following results.
114 (38%) patients dropped out of treatment during the
first 3-month motivational treatment phase primarily be-
cause of relapse to alcohol. 48 (16%) dropped out of treat-
ment during the consecutive 6- to 8-month rehabilitation
phase, while 97 (32 %) of the 301 patients completed the
rehabilitation phase without any relapse.
Discussion
While in Scandinavia, Great Britain and the US a
number of treatment models for outpatient alcohol detox-
ification have been proposed and evaluated [Alsen, 1975;
Alterman et al., 1998; Bjorkquist et al., 1976, O’Connor et
al., 1991; Webb and Unwin, 1988], mostly in specialized
outpatient clinics but partially also at home [Stockwell et
al., 1986], to date in Germany outpatient detoxification is
hardly practiced, at least on a structured basis. The litera-
ture on this subject is still surprisingly limited. In 1998
Wiseman et al. reported a completion rate of 85%, a figure
similar to those found in other studies [Collins et al.,
1990; Alterman et al., 1998; O’Connor et al., 1991; Webb
and Unwin, 1998; Stockwell et al., 1986; Hayashida et al.,
1989; Stinnet, 1982; Feldman et al., 1975]. Still, little is
known about the mid- and long-term efficacy of outpa-
tient detoxification concerning abstinence and motiva-
tion of patients for further treatment.
We report results on the efficacy of an outpatient alco-
hol detoxification program which was launched after
intensive negotiations with major health care insurances
in the outer Munich area in 1998. The study was per-
formed in an outpatient alcohol clinic which already
offered a comprehensive outpatient rehabilitation pro-
gram [Soyka et al., 1997] and had expressed its interest in
a collaboration in this area. The results of this treatment
program with a 94% completion rate of outpatient detox-
ification support the positive results reported by Wise-
man et al. [1997, 1998] and others [Collins et al., 1990;
Alterman et al., 1998; Bjorkquist et al., 1976; Hayashida
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Fig. 4. Overview of alcohol inpatient and outpatient detoxification.
Fig. 5. Clinical outcome after outpatient treatment.
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et al., 1989] and suggest that outpatient alcohol detoxifi-
cation can be considered a safe and effective treatment
option for a subgroup of alcoholic patients.
There are several limitations to our study. First no con-
trol group could be studied to compare effects of outpa-
tient vs. inpatient or the efficacy of the psychotherapeutic
interventions compared to a basically somatic detoxifica-
tion.
While this study was primarily designed to study the
feasibility and safety of the outpatient treatment model,
future research will address the mid- and long-term out-
come of outpatient detoxification compared to inpatient
treatment.
Second, both for inpatient and outpatient treatment of
alcoholics, setting effects have to be considered [Finney et
al., 1996]. Although the patients included in our sample
had a long-term alcohol history, the level of psychiatric
comorbidity was probably lower compared to patients
seen in other detoxification wards. In other studies pa-
tients with high psychiatric severity and/or poor social
support were found to benefit more from inpatient com-
pared to outpatient treatment [Pettinati et al., 1993].
From a methodological point of view it seems notewor-
thy that the treatment program evaluated in our study had
been conducted in a highly structured outpatient clinic
offering an intensive post-detoxification outpatient treat-
ment rehabilitation program. Studies in less intensive out-
patient settings may reveal less favorable results. The clin-
ical management of withdrawal symptoms on an outpa-
tient basis, including adequate dosages of appropriate
medications and treatment of comorbid psychiatric or
medical disorders, deserves future attention. In most of
the studies quoted about hypnotics, benzodiazepines were
predominantly used for treatment of withdrawal symp-
toms either in a fixed dosage regime [Collins et al., 1990]
or on an individualized, symptom-oriented basis [Wise-
man et al., 1998]. Other authors favor the use of anticon-
vulsants [Longo et al., 2002], especially carbamazepine
[Malcolm et al., 2002]. Although the effectiveness of ben-
zodiazepines in the treatment of alcohol withdrawal
symptoms has clearly been demonstrated, its use in outpa-
tient withdrawal may be discussed and considered with
caution. At least in Germany the prescription of benzodi-
azepines and other hypnotics such as chlormethiazole to
alcoholics on an outpatient basis is controversial predom-
inantly because of the risk of over-sedation/intoxication
and the apparent abuse potential. In the program re-
ported, doxepine and/or clonidine respectively carbama-
zepine/tiapride were given if necessary and the clinical
impression and treatment results concerning medical
complications and feasibility of treatment were quite
favorable. Since this study was not primarily designed to
evaluate different pharmacological regimes in outpatient
detoxification, these results may be considered to be pre-
liminary in some respects but future studies and a more
detailed analysis of this continuing program may address
this question in more detail.
In conclusion, the clinical results of the outpatient
detoxification program presented suggest that this thera-
peutic approach is safe and practical. Future studies
should focus on different treatment settings (outpatient
clinic vs. home detoxification), individual variables pre-
dicting outcome, evaluation of different pharmacological
regimes for outpatient treatment including antidepres-
sants and carbamazepine [Bjorkquist et al., 1976] that
might minimize the risk for secondary drug dependence
and socioeconomic factors (cost-benefit ratio), among
others.
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